arrow
M

Maëlle Duffey

Medicines for Malaria Venture
H指数:14
被引数:787

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

In vitro activity of flomoxef, fosfomycin and amikacin versus a global panel of third-generation cephalosporin-resistant Enterobacterales and prediction of their ability in pairwise combinations to work as carbapenem-sparing regimens

体外氟莫克西、磷霉素和阿米卡星对全球第三代头孢菌素耐药肠杆菌科细菌的活性及预测其两两组合作为碳青霉烯类节约方案的能力

2026-09-070
OAAI
Mechanisms of PfDNMT2 inhibition and PfATP6-mediated resistance to the antimalarial candidate SC83288 in Plasmodium falciparum

恶性疟原虫中PfDNMT2抑制机制和PfATP6介导的对抗疟候选药物SC83288的耐药性

2026-03-060
OAAI
Ex vivo susceptibilities to ganaplacide and diversity in potential resistance mediators in Ugandan Plasmodium falciparum isolates

乌干达恶性疟原虫分离株对ganaplacide的离体敏感性和潜在抗性介质的多样性

2024-09-040
PRE
Susceptibility of Ugandan Plasmodium falciparum Isolates to the Antimalarial Drug Pipeline
2023-06-154
OAAI
Mitigating the risk of antimalarial resistance via covalent dual-subunit inhibition of the Plasmodium proteasome
2023-05-0113
OAAI
Potent acyl-CoA synthetase 10 inhibitors kill Plasmodium falciparum by disrupting triglyceride formation
2023-03-1610
OAAI
Susceptibilities of Ugandan Plasmodium falciparum Isolates to Proteasome Inhibitors

乌干达恶性疟原虫分离株对蛋白酶体抑制剂的敏感性

2022-10-185
OA
Discovery and Characterization of Potent, Efficacious, Orally Available Antimalarial Plasmepsin X Inhibitors and Preclinical Safety Assessment of UCB7362

有效,有效,口服可用的抗疟血浆蛋白酶X抑制剂的发现和表征以及UCB7362的临床前安全性评估

2022-10-1016
OAAI
The Plasmodium falciparum ABC transporter ABCI3 confers parasite strain-dependent pleiotropic antimalarial drug resistance
2022-05-0118
OAAI
Associations between Varied Susceptibilities to PfATP4 Inhibitors and Genotypes in Ugandan Plasmodium falciparum Isolates
2021-09-172
OA
Decreased Susceptibility to Dihydrofolate Reductase Inhibitors Associated With Genetic Polymorphisms in Ugandan Plasmodium falciparum Isolates

乌干达恶性疟原虫分离株对与遗传多态性相关的二氢叶酸还原酶抑制剂的易感性降低

2021-08-307
OA